Webinar: New Models for Respiratory Drug Product Development and Assessment
Development of new drug products for delivery via the respiratory system- for local or systemic effect- can be difficult and risky due to complications in distribution, permeation and penetration, clearance, and efficacy.
In order to support the development of respiratory therapeutics, MedPharm’s Research Biology & Innovation team is developing new model systems and formulation testing systems with the aim of de-risking drug products prior to the start of clinical trials. In this webinar, audience members will hear directly from the team members behind developing and creating these innovative models.
Watch the webinar below to learn about MedPharm’s models for assessing:
- Delivery to the nose
- Delivery through respiratory epithelia
- Drug activity in pulmonary fibrotic disease
- Mucociliary clearance